CONTROLLED-RELEASE FORMULATIONS OF PROPRANOLOL AND VERAPAMIL

被引：1
作者：
DUNN, J
机构：
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 01期
关键词：
D O I：
10.1177/009127008702700104
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22 / 31
页数：10
相关论文
共 79 条
[1]   FAMILY STUDY OF GENETIC AND ENVIRONMENTAL-FACTORS DETERMINING THE PROTEIN-BINDING OF PROPRANOLOL [J].
ALVAN, G ;
BERGSTROM, K ;
BORGA, O ;
ISELIUS, L ;
PEDERSEN, N .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (04) :437-441
[2]   CLINICAL PHARMACOKINETICS OF VERAPAMIL IN PATIENTS WITH ATRIAL-FIBRILLATION [J].
ANDERSON, P ;
BONDESSON, U ;
SYLVEN, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 23 (01) :49-57
[3]  
ANDREASEN F, 1975, European Journal of Cardiology, V2, P443
[4]  
BALASUBRAMANIAN V, 1980, LANCET, V1, P841
[5]   BIOLOGICAL PROPERTIES OF OPTICAL ISOMERS OF PROPRANOLOL AND THEIR EFFECTS ON CARDIAC ARRHYTHMIAS [J].
BARRETT, AM ;
CULLUM, VA .
BRITISH JOURNAL OF PHARMACOLOGY, 1968, 34 (01) :43-+
[6]   A COMPARISON OF EFFECTS OF (+-)-PROPRANOLOL AND (+)-PROPRANOLOL IN ANAESTHETIZED DOGS - BETA-RECEPTOR BLOCKING AND HAEMODYNAMIC ACTION [J].
BARRETT, AM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (04) :241-&
[7]  
BENDER F, 1970, ARZNEI-FORSCHUNG, V20, P1310
[8]   PHARMACOKINETICS OF PROPRANOLOL [J].
BORGSTROM, L ;
JOHANSSON, CG ;
LARSSON, H ;
LENANDER, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :419-429
[9]   CONTRIBUTION OF INDIVIDUAL-DIFFERENCES IN GASTRIC-EMPTYING TO VARIABILITY IN PLASMA PROPRANOLOL CONCENTRATIONS [J].
CASTLEDEN, CM ;
GEORGE, CF ;
SHORT, MD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (02) :121-122
[10]   EFFECT OF AGING ON THE HEPATIC CLEARANCE OF PROPRANOLOL [J].
CASTLEDEN, CM ;
GEORGE, CF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (01) :49-54
12345678